← SynDRA
foxy-5
SynDRA canonical compound SYN0062659 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | WNT5A |
|---|
| Mechanism of action | WNT5a peptide mimetic |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Foxy5
- N-formyl-met-asp-gly-cys-glu-leu
- Wnt-5a derived hexapeptide foxy-5
- Wnt-5a mimetic (peptide, breast cancer metastasis), WntResearch
- FOXY5
- N-Formyl-Met-Asp-Gly-Cys-Glu-Leu
- WNT-5A derived hexapeptide FOXY-5
- UNII-CBZ9UL0ARB
- RefChem:141406
- FOXY 5 [WHO-DD]
- Wnt-5a Mimic Hexapeptide Foxy-5
- CBZ9UL0ARB
- Wnt5a hexapeptide
- Foxy 5 TFA
- orb1983958
- Foxy-5(Wnt5a peptide mimetic)
- SCHEMBL23477401
- formyl-Met-Asp-Gly-Cys-Glu-Leu
- Foxy-5(Wnt5a peptide mimetic)?
- CHEBI:125492
- For-Met-Asp-Gly-Cys-Glu-Leu-OH
- GLXC-21556
- C26H42N6O12S2
- EX-A4066
- HY-P1416
- MFCD30182296
- TP1565
- AKOS025147366
- CCG-208076
- NCGC00689109-01
- DA-73540
- MS-33140
- CS-0033287
- NS00072887
- BRD-K13005598-001-01-5
- BRD-K13005598-001-02-3
Look up foxy-5 in the interactive SynDRA portal →